Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Carnitine in Heart Failure Patients
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Summary
Heart failure is a condition in which the heart is unable to pump blood effectively, leading to symptoms like being more tired, shortness of breath, and swelling in the body. Carnitine is a naturally occurring substance in the body that plays a role in turning fat into energy. This study will determine whether oral L-Carnitine supplementation can improve symptoms, enhance heart function and possibly improve the quality of life in individuals with heart failure.
Official title: Oral L-Carnitine Supplementation in Cardiorenal Heart Failure Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-12-01
Completion Date
2026-12-31
Last Updated
2025-10-01
Healthy Volunteers
No
Conditions
Interventions
Levocarnitine
Oral L-carnitine, 2970mg daily (950mg, to be taken 3 times a day) for 3 months.
Locations (1)
London Health Sciences Centre
London, Ontario, Canada